Dr. Edgardo Santos' Interview with Sanjiv Agarwala, MD, FASCO
Update: 2025-08-25
Description
Interviews with Summit Director Edgardo S. Santos Castillero, MD, FACP, FASCO
NOSCM 2024 | New Orleans Summer Cancer Meeting
NOSCM
Dr. Edgardo Santos' Interview with Sanjiv Agarwala, MD, FASCO
Dr. Sanjeev Agarwalareviewed advances in melanoma therapy, highlighting promising phase II results combining RNA-based vaccines with pembrolizumab, which enhanced anti-tumor response without added toxicity. He noted that dual LAG-3/PD-1 blockade offersefficacy comparable to ipilimumab/nivolumab but with a more favorable safety profile and neoadjuvant ipilimumab for stage III melanoma, which may obviate the need for additional post-surgical treatments.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
